Advanced Search
Latest accepted have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Articles in press have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Progress of Research on Radiotherapy for Advanced Esophageal Cancer in the Era of Immunotherapy
2024, 51(6): 397-401. DOI: 10.3971/j.issn.1000-8578.2024.24.0065
Abstract FullText HTML PDF
Shikonin Inhibits APC-mutant Colon Cancer via Wnt/β-catenin Signaling
CHEN Lizhe, WANG Bojun, GONG Qing, ZHANG Xue, KE Xisong
2024, 51(6): 402-408. DOI: 10.3971/j.issn.1000-8578.2024.24.0121
Abstract FullText HTML PDF
Immunotherapy for Advanced Non-small Cell Lung Cancer: Research Progress and Perspectives
WANG Jingyi, ZHONG Yuling, WU Lin
2024, 51(6): 409-418. DOI: 10.3971/j.issn.1000-8578.2024.24.0090
Abstract FullText HTML PDF
DCLK1 Promotes Malignancy of A549 Cell Line by Activating FAK/PI3K/AKT/mTOR Pathway
YAN Rui, XIAO Zeru, HUANG Xuying, AN Guangyu, GE Yang
2024, 51(6): 419-425. DOI: 10.3971/j.issn.1000-8578.2024.23.1355
Abstract FullText HTML PDF
Experimental Study on Treatment of Gastric Cancer with New Recombinant Oncolytic Vaccinia Virus Infection Combined with Immune Effective Cells and Immune Checkpoint Blocking
ZHANG Lin, HOU Yanhong, WU Kai, ZHANG Jing
2024, 51(6): 426-431. DOI: 10.3971/j.issn.1000-8578.2024.23.1380
Abstract FullText HTML PDF
miR-378a-3p Targets NUAK2 to Inhibit Proliferation, Migration, and Invasion of Breast Cancer Cells
CHEN Jianbin, WANG Tairen
2024, 51(6): 432-439. DOI: 10.3971/j.issn.1000-8578.2024.23.1216
Abstract FullText HTML PDF
AAMP Promotes Osteosarcoma Cell Metastasis by Regulating YAP Signaling Pathway
DENG Qianrong, ZHAN Fangbiao, XIE Chaozheng, XIANG Shuang, CHEN Jian, YANG Yi
2024, 51(6): 440-447. DOI: 10.3971/j.issn.1000-8578.2024.23.1034
Abstract FullText HTML PDF
Visualization Analysis of Research Hotspots of Breast Cancer Microenvironment Based on CiteSpace and VOSviewer
FANG Yuhang, XIE Yi, YANG Shuhan, LIU Suying, FANG Liyuan, WANG Yan, WANG Runxi, ZHANG Ying
2024, 51(6): 448-454. DOI: 10.3971/j.issn.1000-8578.2024.24.0004
Abstract FullText HTML PDF
Molecular Pathological Risk Grade Evaluates Biological Behavior and Prognosis of Patients with WHO Grade 1 Meningiomas
ZENG Lingcheng, LI Hua, CHEN Rudong, YANG Hongkuan, CHEN Jian, YU Jiasheng
2024, 51(6): 455-461. DOI: 10.3971/j.issn.1000-8578.2024.23.1342
Abstract FullText HTML PDF
Prediction of Risk of Cardiac Adverse Events After Chemotherapy Based on Acoustic Cardiography-Blood Index Nomogram
LIU Yan, LI Yuanfei, ZHANG Wenping, JIA Rui, PING Mei
2024, 51(6): 462-468. DOI: 10.3971/j.issn.1000-8578.2024.23.1352
Abstract FullText HTML PDF
Clinicopathological Analysis of 11 Cases of SMARCA4 (BRG1)-deficient Carcinoma
JIANG Xiaozhen, GUO Fengfen, SHENG Yiyun, LIANG Shengnan, WAN Hongping, DENG Kui
2024, 51(6): 469-474. DOI: 10.3971/j.issn.1000-8578.2024.23.1121
Abstract FullText HTML PDF
Research Progress of Anti-cancer Strategies Based on ERK1/2 Post-translational Modification and Spatial Regulation
GUO Ting, SHANG Mengyu, GUO Yin, HUANG Weiren
2024, 51(6): 475-483. DOI: 10.3971/j.issn.1000-8578.2024.23.1332
Abstract FullText HTML PDF
Correlation Between Peripheral Blood Inflammatory Markers and 18F-FDG PET/CT Metabolic Parameters in Tumors
TONG Yilin, QIU Dasheng
2024, 51(6): 484-487. DOI: 10.3971/j.issn.1000-8578.2024.24.0080
Abstract FullText HTML PDF
Progress of Research on Regional Differences in Esophageal Cancer
CHEN Yu, CAI Wenke, LUO Xiaodi, HE Yongneng, TU Dong
2024, 51(6): 488-494. DOI: 10.3971/j.issn.1000-8578.2024.23.1227
Abstract FullText HTML PDF
Standardization for Diagnosis and Treatment of Primary Hepatic Carcinoma (2024 Edition)
National Health Commission of the People’s Republic of China
2024, 51(6): 495-526. DOI: 10.3971/j.issn.1000-8578.2024.06.0001
Abstract FullText HTML PDF

Special Issues